PHARMAC responds on long-acting insulin analogues.

The New Zealand medical journal

Volumn 118, Issue 1224, 2005, Pages

  Metcalfe, Scott ^a   Evans, Jackie ^a   Moodie, Peter ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; LONG ACTING INSULIN;

COST BENEFIT ANALYSIS; DIABETES MELLITUS; DRUG APPROVAL; ECONOMICS; HEALTH CARE ORGANIZATION; HUMAN; NEW ZEALAND; NOTE; PUBLIC HEALTH;

COST-BENEFIT ANALYSIS; DIABETES MELLITUS; DRUG APPROVAL; HEALTH CARE RATIONING; HUMANS; INSULIN, LONG-ACTING; NATIONAL HEALTH PROGRAMS; NEW ZEALAND;

EID: 33644826709     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Note

References (0)